[Federal Register Volume 60, Number 23 (Friday, February 3, 1995)]
[Notices]
[Page 6713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-2629]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 95G-0009]
American Dairy Products Institute; Filing of Petition for
Affirmation of GRAS Status
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that the
American Dairy Products Institute has filed a petition (GRASP 1G0371),
proposing to affirm that whey protein isolate and dairy product solids
are generally recognized as safe (GRAS) as direct human food
ingredients and to broaden the specifications for reduced lactose whey,
reduced minerals whey, and whey protein concentrate.
DATES: Written comments by April 4, 1995.
ADDRESSES: Submit written comments to the Dockets Management Branch
(HFA-305), Food and Drug Administration, rm. 1-23, 12420 Parklawn Dr.,
Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: Rudolph Harris, Center for Food Safety
and Applied Nutrition (HFS-207), Food and Drug Administration, 200 C
St. SW., Washington, DC 20204, 202-418-3090.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (secs. 201(s) and 409(b)(5) (21 U.S.C. 321(s) and 348(b)(5)) and
the regulations for affirmation of GRAS status in Sec. 170.35 (21 CFR
170.35), notice is given that the American Dairy Products Institute,
130 North Franklin St., Chicago, IL., (c/o Keller and Heckman,
Washington, DC) has filed a petition (GRASP 1G0371), proposing that
whey protein isolate and dairy product solids be affirmed as GRAS for
use as direct human food ingredients, and to broaden the specifications
for reduced lactose whey, reduced minerals whey, and whey protein
concentrate.
The petition has been placed on display at the Dockets Management
Branch (address above).
Any petition that meets the requirements outlined in Secs. 170.30
(21 CFR 170.30) and 170.35 is filed by the agency. There is no
prefiling review of the adequacy of data to support a GRAS conclusion.
Thus, the filing of a petition for GRAS affirmation should not be
interpreted as a preliminary indication of suitability for GRAS
affirmation.
The potential environmental impact of this action is being
reviewed. If the agency finds that an environmental impact statement is
not required and this petition results in a regulation, the notice of
availability of the agency's finding of no significant impact and the
evidence supporting that finding will be published with the regulation
in the Federal Register in accordance with 21 CFR 25.40(c).
Interested persons may, on or before April 4, 1995, review the
petition and file comments with the Dockets Management Branch (address
above). Two copies of any comments should be filed and should be
identified with the docket number found in brackets in the heading of
this document. Comments should include any available information that
would be helpful in determining whether the substance is, or is not,
GRAS for the proposed use. In addition, consistent with the regulations
promulgated under the National Environmental Policy Act (40 CFR
1501.4(b)), the agency encourages public participation by review of and
comment on the environmental assessment submitted with the petition
that is the subject of this notice. A copy of the petition (including
the environmental assessment) and received comments may be seen in the
Dockets Management Branch between 9 a.m. and 4 p.m., Monday through
Friday.
Dated: January 26, 1995.
Alan M. Rulis,
Acting Director, Office of Premarket Approval, Center for Food Safety
and Applied Nutrition.
[FR Doc. 95-2629 Filed 2-2-95; 8:45 am]
BILLING CODE 4160-01-F
